{
    "startDate": "2018-01-01",
    "endDate": "2018-06-30",
    "year": "2018",
    "quarter": "Q2",
    "symbol": "OXGN",
    "data": {
        "bs": [
            {
                "label": "Other Assets, Noncurrent",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 33000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 2099000
            },
            {
                "label": "Cash and Cash Equivalents, at Carrying Value",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1966000
            },
            {
                "label": "Prepaid Expense and Other Assets, Current",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Assets, Current",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 2066000
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Liabilities and Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 2099000
            },
            {
                "label": "Accounts Payable, Current",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1221000
            },
            {
                "label": "Accrued Employee Benefits, Current",
                "concept": "AccruedEmployeeBenefitsCurrent",
                "unit": "usd",
                "value": 40000
            },
            {
                "label": "Accrued Clinical Trial Expenses",
                "concept": "oxgn:AccruedClinicalTrialExpenses",
                "unit": "usd",
                "value": 128000
            },
            {
                "label": "Other Accrued Liabilities, Current",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 172000
            },
            {
                "label": "Liabilities, Current",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 1561000
            },
            {
                "label": "Preferred Stock, Value, Issued",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common Stock, Value, Issued",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 414000
            },
            {
                "label": "Additional Paid in Capital, Common Stock",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 293835000
            },
            {
                "label": "Retained Earnings (Accumulated Deficit)",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -293711000
            },
            {
                "label": "Stockholders' Equity Attributable to Parent",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 538000
            }
        ],
        "cf": [
            {
                "label": "Gain loss on change in fair value of warrant",
                "concept": "oxgn:GainLossOnChangeInFairValueOfWarrant",
                "unit": "usd",
                "value": 250000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Share-based Compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 343000
            },
            {
                "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 78000
            },
            {
                "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -88000
            },
            {
                "label": "Proceeds from Issuance of Common Stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 2358000
            },
            {
                "label": "Net Income (Loss) Attributable to Parent",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -1436000
            },
            {
                "label": "Net Cash Provided by (Used in) Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -1507000
            },
            {
                "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 851000
            }
        ],
        "ic": [
            {
                "label": "Operating Income (Loss)",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -1693000
            },
            {
                "label": "Gain loss on change in fair value of warrant",
                "concept": "oxgn:GainLossOnChangeInFairValueOfWarrant",
                "unit": "usd",
                "value": 250000
            },
            {
                "label": "Investment Income, Interest",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 8000
            },
            {
                "label": "Other Nonoperating Income (Expense)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Net Income (Loss) Attributable to Parent",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -1436000
            },
            {
                "label": "Earnings Per Share, Basic and Diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.04
            },
            {
                "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 33012000
            },
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 567000
            },
            {
                "label": "General and Administrative Expense",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1126000
            },
            {
                "label": "Operating Expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 1693000
            }
        ]
    }
}